Health Care & Life Sciences » Pharmaceuticals » Novartis | Novartis R&D expenditure as percent of revenue 2004-2017

Novartis' R&D expenditure as a percent of revenue 2004-2017

Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2017

The data describes Novartis expenditure on research and development, from 2004 to 2017, as a percent of revenue. In 2008, research and development expenditure accounted for about 17.4% of Novartis' total revenue.

2004	16
2005	16
2006	15
2007	17
2008	17.4
2009	16.5
2010	16
2011	16.3
2012	16.4
2013	17.1
2014	16.7
2015	17.7
2016	17.3
2017	16.9

Novartis' R&D expenditure as a percent of revenue 2004-2017

StatInvestor